Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vaneck Pharmaceutical ETF (PPH)

Vaneck Pharmaceutical ETF (PPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 657,931,700
  • Shares Outstanding, K 7,390
  • 60-Month Beta 0.72
  • Price/Earnings ttm 15.43
  • Annual Dividend & Yield 1.61 (1.80%)
  • Most Recent Dividend 0.409 on 10/01/24
  • Management Fee 0.36%
  • Sectors:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 13.00% ( +0.39%)
  • Historical Volatility 12.40%
  • IV Percentile 61%
  • IV Rank 25.38%
  • IV High 23.15% on 08/05/24
  • IV Low 9.54% on 11/13/24
  • Put/Call Vol Ratio 14.86
  • Today's Volume 111
  • Volume Avg (30-Day) 320
  • Put/Call OI Ratio 12.84
  • Today's Open Interest 4,289
  • Open Int (30-Day) 3,301

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.99 +3.54%
on 11/19/24
91.34 -2.53%
on 11/11/24
-1.92 (-2.11%)
since 11/08/24
3-Month
85.99 +3.54%
on 11/19/24
98.30 -9.43%
on 09/16/24
-8.00 (-8.24%)
since 09/10/24
52-Week
78.19 +13.86%
on 12/11/23
99.51 -10.53%
on 09/03/24
+10.60 (+13.51%)
since 12/08/23

Most Recent Stories

More News
Winners and Losers: Post-Election Options Analysis

Investors are anticipating which sectors might be most affected by the Trump administration. Brett Friedman, Winhall Risk Analytics/OptionMetrics Contributor takes a look at options data and implied volatility...

XLE : 90.25 (-0.68%)
ITA : 149.78 (+0.32%)
PPH : 89.03 (-1.06%)
^BTCUSD : 97,497.72 (+0.57%)
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink?

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

HON : 229.08 (+1.77%)
$SPX : 6,034.91 (-0.30%)
COR : 237.01 (-1.46%)
PPH : 89.03 (-1.06%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 68.55 (-0.45%)
BE : 23.47 (-11.70%)
CVX : 157.00 (-0.05%)
JPM : 242.86 (-0.39%)
MRK : 101.00 (-2.69%)
IHE : 67.95 (-0.79%)
PPH : 89.03 (-1.06%)
UNH : 565.19 (+0.82%)
PFE : 25.57 (-2.03%)
KBH : 77.20 (-2.86%)
XLE : 90.25 (-0.68%)
XHB : 117.53 (-2.01%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 144.10 (-0.41%)
JNJ : 149.23 (-0.25%)
IHE : 67.95 (-0.79%)
IYH : 60.97 (-0.39%)
PPH : 89.03 (-1.06%)
FTXH : 27.83 (-0.93%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 109.19 (-1.70%)
LLY : 799.58 (-0.50%)
HRTS : 32.47 (-0.28%)
PPH : 89.03 (-1.06%)
THNR : 24.01 (-1.49%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 109.19 (-1.70%)
LLY : 799.58 (-0.50%)
HRTS : 32.47 (-0.28%)
PPH : 89.03 (-1.06%)
THNR : 24.01 (-1.49%)
Is Wall Street Bullish or Bearish on Cencora Stock?

Cencora has outperformed the broader market over the past year, and Wall Street analysts remain bullish about the stock's prospects.

COR : 237.01 (-1.46%)
$SPX : 6,034.91 (-0.30%)
PPH : 89.03 (-1.06%)
What Are Wall Street Analysts' Target Price for Abbvie Stock?

Despite AbbVie stock’s robust price performance compared to the broader market over the past year, Wall Street analysts are moderately bullish about the stock’s prospects.

ABBV : 175.67 (-0.51%)
$SPX : 6,034.91 (-0.30%)
PPH : 89.03 (-1.06%)
CERE : 44.96 (+0.74%)
WFC : 72.05 (-0.78%)
Abbvie Stock: Is Wall Street Bullish or Bearish?

Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.

ABBV : 175.67 (-0.51%)
$SPX : 6,034.91 (-0.30%)
PPH : 89.03 (-1.06%)
Profiting From the Bud Light Brouhaha

As the great Warren Buffet was once quoted as saying "Be fearful when others are greedy, and greedy when others are fearful". With all the chaos surrounding the recent Bud Light marketing debacle, there...

BUD : 52.96 (-0.19%)
PPH : 89.03 (-1.06%)
STZ : 242.60 (-0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 91.26
2nd Resistance Point 90.75
1st Resistance Point 89.89
Last Price 89.03
1st Support Level 88.52
2nd Support Level 88.01
3rd Support Level 87.15

See More

52-Week High 99.51
Fibonacci 61.8% 91.37
Last Price 89.03
Fibonacci 50% 88.85
Fibonacci 38.2% 86.33
52-Week Low 78.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar